Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Anton Bespalov; Thomas Steckler; Bruce Altevogt; Elena Koustova; Phil Skolnick; Daniel Deaver; Mark J. Millan; Jesper F. Bastlund; Dario Doller; Jeffrey Witkin; Paul Moser; Patricio O'Donnell; Ulrich Ebert; Mark A. Geyer; Eric Prinssen; Theresa Ballard; Malcolm Macleod

doi:10.1038/nrd.2016.88

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Anton Bespalov^*, Thomas Steckler, Bruce Altevogt, Elena Koustova, Phil Skolnick, Daniel Deaver, Mark J. Millan, Jesper F. Bastlund, Dario Doller, Jeffrey Witkin, Paul Moser, Patricio O'Donnell, Ulrich Ebert, Mark A. Geyer, Eric Prinssen, Theresa Ballard, Malcolm Macleod

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Number of pages	1
Journal	Nature Reviews Drug Discovery
Volume	15
Issue number	7
DOIs	https://doi.org/10.1038/nrd.2016.88
Publication status	Published - 30 Jun 2016

Access to Document

10.1038/nrd.2016.88

Cite this

Bespalov, A., Steckler, T., Altevogt, B., Koustova, E., Skolnick, P., Deaver, D., Millan, M. J., Bastlund, J. F., Doller, D., Witkin, J., Moser, P., O'Donnell, P., Ebert, U., Geyer, M. A., Prinssen, E., Ballard, T., & Macleod, M. (2016). Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets. Nature Reviews Drug Discovery, 15(7). https://doi.org/10.1038/nrd.2016.88

@article{3636e2e2d75d4804a8f05b1b87eb278f,

title = "Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets",

author = "Anton Bespalov and Thomas Steckler and Bruce Altevogt and Elena Koustova and Phil Skolnick and Daniel Deaver and Millan, {Mark J.} and Bastlund, {Jesper F.} and Dario Doller and Jeffrey Witkin and Paul Moser and Patricio O'Donnell and Ulrich Ebert and Geyer, {Mark A.} and Eric Prinssen and Theresa Ballard and Malcolm Macleod",

year = "2016",

month = jun,

day = "30",

doi = "10.1038/nrd.2016.88",

language = "English",

volume = "15",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "7",

}

Bespalov, A, Steckler, T, Altevogt, B, Koustova, E, Skolnick, P, Deaver, D, Millan, MJ, Bastlund, JF, Doller, D, Witkin, J, Moser, P, O'Donnell, P, Ebert, U, Geyer, MA, Prinssen, E, Ballard, T & Macleod, M 2016, 'Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets', Nature Reviews Drug Discovery, vol. 15, no. 7. https://doi.org/10.1038/nrd.2016.88

TY - JOUR

T1 - Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

AU - Bespalov, Anton

AU - Steckler, Thomas

AU - Altevogt, Bruce

AU - Koustova, Elena

AU - Skolnick, Phil

AU - Deaver, Daniel

AU - Millan, Mark J.

AU - Bastlund, Jesper F.

AU - Doller, Dario

AU - Witkin, Jeffrey

AU - Moser, Paul

AU - O'Donnell, Patricio

AU - Ebert, Ulrich

AU - Geyer, Mark A.

AU - Prinssen, Eric

AU - Ballard, Theresa

AU - Macleod, Malcolm

PY - 2016/6/30

Y1 - 2016/6/30

UR - http://www.scopus.com/inward/record.url?scp=85013815221&partnerID=8YFLogxK

U2 - 10.1038/nrd.2016.88

DO - 10.1038/nrd.2016.88

M3 - Letter

C2 - 27312728

AN - SCOPUS:85013815221

SN - 1474-1776

VL - 15

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 7

ER -

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Access to Document

Other files and links

Cite this